Alexis Borisy - 22 Jun 2021 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Role: Director
Signature: /s/ Jack Anders, as Attorney-in-fact for Alexis Borisy
Issuer symbol: RVMD
Transactions as of: 22 Jun 2021
Net transactions value: $0
Form type: 4
Filing time: 24 Jun 2021, 17:14:50 UTC
Previous filing: 04 Jun 2021
Next filing: 12 Aug 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RVMD	Common Stock	Award	$0	+3,617	+7.8%	$0.000000	49,718	22 Jun 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RVMD	Stock Option (Right to Buy)	Award	$0	+12,659		$0.000000	12,659	22 Jun 2021	Common Stock	12,659	$32.93	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 3,617 Restricted Stock Units.
F2	On September 10, 2020, December 3, 2020, and February 25, 2021, Third Rock Ventures GP III, L.P. distributed 639, 639 and 43,015 shares, respectively, to the Reporting Person through in-kind, pro rata distributions without value. The distributions were exempt Section 16 of the Exchange Act pursuant to Rule 16a-9.
F3	Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 22, 2021 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date.